Literature DB >> 24994580

Pulmonary involvement in patients with Marfan Syndrome.

A G Corsico1, A Grosso, B Tripon, F Albicini, E Gini, A Mazzetta, E M Di Vincenzo, M E Agnesi, E Tsana Tegomo, V Ronzoni, E Arbustini, I Cerveri.   

Abstract

AIM: Pulmonary involvement is not generally considered a main feature of Marfan syndrome, an autosomal connective tissue disorder caused by mutations in fibrillin 1. Thanks to the substantial progress in treatments, life expectation of these patients has been dramatically improved determining changes in different organ systems. The number of patients with pulmonary pathology may be higher than expected. Objective of the study was to evaluate the pulmonary involvement in all the patients referring to the largest Italian center for Marfan syndrome, assessing clinical examination and lung function tests.
METHODS: Clinical history, spirometry, lung volumes and diffusing capacity have been assessed in 64 patients of our national referral center.
RESULTS: None of the patients reported chronic respiratory symptoms. Fourteen percent reported a previous pneumothorax and 3 blebs and 45% had moderate to severe rib cage abnormalities. Twenty-three percent had cardiothoracic surgery. Two of the 19 patients with chest TC performed at our hospital were diagnosed with emphysema and were both non smoker; 7 had subpleural apical blebs. Only 37% of patients had normal lung function; 19% showed a restrictive pattern and 44% an obstructive pattern or an isolated diffusion impairment or an isolated hyperinflation. All patients with pneumothorax showed an obstructive pattern and diffusion impairment.
CONCLUSION: In the absence of early respiratory symptoms, pulmonary abnormalities should be detected and monitored before they aggravate. Particular attention should be paid to prevent pneumothorax. Our results support the importance of lung volume determination to identify patients in which pulmonary parenchyma require a careful chest CT evaluation.

Entities:  

Mesh:

Year:  2014        PMID: 24994580

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  10 in total

1.  Marfan syndrome with pneumothorax: case report and review of literatures.

Authors:  Weiming Hao; Yong Fang; Hao Lai; Yaxing Shen; Hao Wang; Miao Lin; Lijie Tan
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  The correlation between spinal and chest wall deformities and pulmonary function in Marfan syndrome.

Authors:  Hila Otremski; Roger F Widmann; Mary F Di Maio; Dror Ovadia
Journal:  J Child Orthop       Date:  2020-08-01       Impact factor: 1.548

3.  Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD study.

Authors:  Kana Fujikura; Alessandra Albini; R Graham Barr; Megha Parikh; Julia Kern; Eric Hoffman; Grant T Hiura; David A Bluemke; James Carr; João A C Lima; Erin D Michos; Antoinette S Gomes; Martin R Prince
Journal:  Int J Cardiol       Date:  2021-02-13       Impact factor: 4.164

Review 4.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

Review 5.  The role of the multidisciplinary health care team in the management of patients with Marfan syndrome.

Authors:  Yskert von Kodolitsch; Meike Rybczynski; Marina Vogler; Thomas S Mir; Helke Schüler; Kerstin Kutsche; Georg Rosenberger; Christian Detter; Alexander M Bernhardt; Axel Larena-Avellaneda; Tilo Kölbel; E Sebastian Debus; Malte Schroeder; Stephan J Linke; Bettina Fuisting; Barbara Napp; Anna Lena Kammal; Klaus Püschel; Peter Bannas; Boris A Hoffmann; Nele Gessler; Eva Vahle-Hinz; Bärbel Kahl-Nieke; Götz Thomalla; Christina Weiler-Normann; Gunda Ohm; Stefan Neumann; Dieter Benninghoven; Stefan Blankenberg; Reed E Pyeritz
Journal:  J Multidiscip Healthc       Date:  2016-11-03

6.  Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome.

Authors:  Kathryn Jespersen; Zhibo Liu; Chenxin Li; Paul Harding; Kylie Sestak; Rishi Batra; Christopher A Stephenson; Ryan T Foley; Harrison Greene; Trevor Meisinger; B Timothy Baxter; Wanfen Xiong
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

7.  Lung Function Changes are More Common in Marfan Patients Who Need Major Thoracic Surgery.

Authors:  Abigel M Kolonics-Farkas; Bence Agg; Kalman Benke; Balazs Odler; Aniko Bohacs; Zsuzsanna Kovats; Zoltan Szabolcs; Veronika Müller
Journal:  Lung       Date:  2019-05-14       Impact factor: 2.584

Review 8.  Respiratory manifestations of Marfan syndrome: a narrative review.

Authors:  Mon Hnin Tun; Bryan Borg; Maurice Godfrey; Nancy Hadley-Miller; Edward D Chan
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

9.  Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome.

Authors:  Juan J Uriarte; Thayna Meirelles; Darya Gorbenko Del Blanco; Paula N Nonaka; Noelia Campillo; Elisabet Sarri; Daniel Navajas; Gustavo Egea; Ramon Farré
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

10.  Thoracoscopic Treatment of Pneumothorax in Marfan Syndrome: Hemostatic Patch to Support Lung Resection Recovery.

Authors:  Gloria Pelizzo; Eloisa Arbustini; Noemi Pasqua; Patrizia Morbini; Valeria Calcaterra
Journal:  Case Rep Surg       Date:  2018-09-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.